Loading...
Header Logo
Keywords
Last Name
Institution

Sohail Khan

TitleDirector
InstitutionCherokee Nation Health Services
DepartmentHealth Services
Phone918/454-5000
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Dow Health Sciences University, KarachiMBBS05/1987Medicine
    University of Oklahoma, Oklahoma City, OKMPH05/1992Epidemiology

    Collapse Research 
    Collapse research activities and funding
    S06GM123546     (KHAN, SOHAIL)Sep 15, 2017 - Jul 31, 2021
    NIH
    Cherokee Nation Native American Research Center for Health
    Role: Principal Investigator
    P20CA202923     (KHAN, SOHAIL)Sep 24, 2015 - Aug 31, 2019
    NIH
    1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wang W, Blackett P, Khan S, Lee E. Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee. J Lipids. 2017; 2017:8236325. PMID: 28473926.
      View in: PubMed
    2. Blackett PR, Khan S, Wang W, Alaupovic P, Lee ET. Sex differences in HDL ApoC-III in American Indian youth. Biol Sex Differ. 2012 Aug 16; 3(1):18. PMID: 22898077; PMCID: PMC3526514.
      View in: PubMed, PubMed Central
    3. Gaddy JR, Vista ES, Robertson JM, Dedeke AB, Roberts VC, Klein WS, Levin JH, Mota FH, Cooper TM, Grim GA, Khan S, James JA. Rheumatic disease among Oklahoma tribal populations: a cross-sectional study. J Rheumatol. 2012 Oct; 39(10):1934-41. PMID: 22896022; PMCID: PMC3468952.
      View in: PubMed, PubMed Central
    4. Wang W, Khan S, Blackett P, Alaupovic P, Lee E. Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes. J Clin Lipidol. 2013 Jan-Feb; 7(1):38-42. PMID: 23351581; PMCID: PMC3558999.
      View in: PubMed, PubMed Central
    5. Kelly D, Squire IB, Khan SQ, Dhillon O, Narayan H, Ng KH, Quinn P, Davies JE, Ng LL. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction. Am J Cardiol. 2010 Aug 15; 106(4):477-82. PMID: 20691304.
      View in: PubMed
    6. Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J. 2009 May; 30(9):1057-65. PMID: 19168526.
      View in: PubMed
    7. Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2008 May 13; 51(19):1857-64. PMID: 18466800.
      View in: PubMed
    8. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007 Apr 24; 115(16):2103-10. PMID: 17420344.
      View in: PubMed
    Khan's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (52) concept(s)
    _
    Co-Authors Expand Description
    See all (4) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department